mycophenolic acid [Ligand Id: 6832] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL866 (68618, Mycophenolate, Mycophenolate mofetil impurity, mycophenolic acid-, Mycophenolic acid, Myfortic, NSC-129185, RS-61443 [AS MOFETIL])
  • Inosine-5`-monophosphate dehydrogenase in Cryptococcus neoformans var. neoformans serotype D (strain JEC21 /ATCC MYA-565) (Filobasidiella neoformans) [ChEMBL: CHEMBL4295605] [UniProtKB: Q5KP44]
There should be some charts here, you may need to enable JavaScript!
  • inosine monophosphate dehydrogenase 1/Inosine-5`-monophosphate dehydrogenase 1 in Human [ChEMBL: CHEMBL1822] [GtoPdb: 2624] [UniProtKB: P20839]
There should be some charts here, you may need to enable JavaScript!
  • inosine monophosphate dehydrogenase 2/Inosine-5`-monophosphate dehydrogenase 2 in Human [ChEMBL: CHEMBL2002] [GtoPdb: 2625] [UniProtKB: P12268]
There should be some charts here, you may need to enable JavaScript!
There should be some charts here, you may need to enable JavaScript!
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
Inosine-5`-monophosphate dehydrogenase in Cryptococcus neoformans var. neoformans serotype D (strain JEC21 /ATCC MYA-565) (Filobasidiella neoformans) (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4295605] [UniProtKB: Q5KP44]
ChEMBL Inhibition of recombinant Cryptococcus neoformans His-tagged IMPDH expressed in Escherichia coli BL21 (DE3) using IMP as substrate in presence of NAD B 6.92 pIC50 120 nM IC50 Bioorg Med Chem (2018) 26: 5408-5419 [PMID:30322754]
inosine monophosphate dehydrogenase 1/Inosine-5`-monophosphate dehydrogenase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1822] [GtoPdb: 2624] [UniProtKB: P20839]
ChEMBL Inhibition of human IMPDH 1 B 7.4 pKi 40 nM Ki J Med Chem (2007) 50: 6685-6691 [PMID:18038969]
ChEMBL Inhibitory activity against human Inosine-5'-monophosphate dehydrogenase 1 (IMPDH type I) B 7.4 pKi 40 nM Ki J Med Chem (2002) 45: 703-712 [PMID:11806722]
ChEMBL Inhibition of human IMPDH1 B 7.4 pKi 40 nM Ki Bioorg Med Chem (2008) 16: 9340-9345 [PMID:18809333]
ChEMBL Inhibition of human IMP dehydrogenase 1 B 7.4 pKi 40 nM Ki Bioorg Med Chem (2008) 16: 7462-7469 [PMID:18583139]
ChEMBL Inhibitory activity against human Inosine-5'-monophosphate dehydrogenase 1 (IMPDH type I isoform); Range is 33-37 nM B 7.48 pKi 33 nM Ki J Med Chem (1998) 41: 618-622 [PMID:9484510]
ChEMBL Inhibition of human IMPDH type 1 B 7.48 pKi 33 nM Ki J Med Chem (2007) 50: 5743-5751 [PMID:17958343]
ChEMBL Inhibition of human IMPDH1 by Spectrophotometry B 7.48 pKi 33 nM Ki Bioorg Med Chem (2011) 19: 1594-1605 [PMID:21324702]
ChEMBL Inhibition of recombinant human His-tagged IMPDH1 expressed in Escherichia coli BL21 (DE3) using IMP as substrate in presence of NAD B 6.59 pIC50 260 nM IC50 Bioorg Med Chem (2018) 26: 5408-5419 [PMID:30322754]
ChEMBL Inhibitory activity against inosine monophosphate dehydrogenase IMPDH type I B 7.26 pIC50 55 nM IC50 Bioorg Med Chem Lett (2003) 13: 543-546 [PMID:12565968]
ChEMBL Inhibition of human IMPDH1 B 7.49 pIC50 32 nM IC50 Bioorg Med Chem Lett (2006) 16: 3479-3483 [PMID:16621550]
ChEMBL In vitro inhibition of inosine Inosine-5'-monophosphate dehydrogenase B 7.7 pIC50 20 nM IC50 J Med Chem (1990) 33: 833-838 [PMID:1967654]
GtoPdb Reference does not distinguish which enzyme isoform is assayed - 7.7 pIC50 20 nM IC50 J Med Chem (1990) 33: 833-8 [PMID:1967654]
ChEMBL Inhibition of human IMPDH1 expressed in Escherichia coli strain BL21(DE3) after 60 mins B 7.72 pIC50 19 nM IC50 Bioorg Med Chem (2010) 18: 8106-8111 [PMID:20934342]
inosine monophosphate dehydrogenase 2/Inosine-5`-monophosphate dehydrogenase 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2002] [GtoPdb: 2625] [UniProtKB: P12268]
ChEMBL Inhibition of human IMPDH 2 B 8 pKi 10 nM Ki J Med Chem (2007) 50: 6685-6691 [PMID:18038969]
ChEMBL Inhibitory activity against human Inosine-5'-monophosphate dehydrogenase 2 (IMPDH type II) B 8 pKi 10 nM Ki J Med Chem (2002) 45: 703-712 [PMID:11806722]
ChEMBL Inhibition of human IMPDH2 B 8 pKi 10 nM Ki Bioorg Med Chem (2008) 16: 9340-9345 [PMID:18809333]
ChEMBL Inhibition of human IMP dehydrogenase 2 B 8 pKi 10 nM Ki Bioorg Med Chem (2008) 16: 7462-7469 [PMID:18583139]
ChEMBL Inhibition of human IMPDH type 2 B 8.15 pKi 7 nM Ki J Med Chem (2007) 50: 5743-5751 [PMID:17958343]
ChEMBL Inhibition of human IMPDH2 by Spectrophotometer B 8.15 pKi 7 nM Ki Bioorg Med Chem (2011) 19: 1594-1605 [PMID:21324702]
ChEMBL Inhibitory activity against human Inosine-5'-monophosphate dehydrogenase 2 (IMPDH type II isoform); Range is 6-10 nM B 8.22 pKi 6 nM Ki J Med Chem (1998) 41: 618-622 [PMID:9484510]
ChEMBL Inhibition of IMPDH2 B 5.82 pIC50 1500 nM IC50 Bioorg Med Chem Lett (2012) 22: 53-56 [PMID:22172700]
ChEMBL Inhibition of IMPDH2 using inosine 5'-monophosphate as substrate by spectrophotometry B 6.2 pIC50 630 nM IC50 Bioorg Med Chem Lett (2012) 22: 3332-3335 [PMID:22464133]
ChEMBL Inhibition of human IMPDH2 using IMP as substrate in presence of NAD+ after 30 mins B 6.6 pIC50 250 nM IC50 Eur J Med Chem (2018) 158: 286-301 [PMID:30223117]
ChEMBL Inhibition of recombinant human His-tagged IMPDH2 expressed in Escherichia coli BL21 (DE3) using IMP as substrate in presence of NAD B 6.96 pIC50 110 nM IC50 Bioorg Med Chem (2018) 26: 5408-5419 [PMID:30322754]
ChEMBL Compound was tested for inhibition of human recombinant type II Inosine Monophosphate Dehydrogenase at pH 7.4 B 7.6 pIC50 25.1 nM IC50 J Med Chem (1996) 39: 4181-4196 [PMID:8863796]
ChEMBL Compound was tested for inhibition of human recombinant type II Inosine Monophosphate Dehydrogenase at pH 8.0 B 7.61 pIC50 24.8 nM IC50 J Med Chem (1996) 39: 4181-4196 [PMID:8863796]
GtoPdb Reference does not distinguish which enzyme isoform is assayed - 7.7 pIC50 20 nM IC50 J Med Chem (1990) 33: 833-8 [PMID:1967654]
ChEMBL Inhibition of human IMPDH2 B 7.8 pIC50 16 nM IC50 J Med Chem (2007) 50: 3730-3742 [PMID:17585753]
ChEMBL In vitro inhibition of Inosine-5'-monophosphate dehydrogenase 2. B 7.82 pIC50 15 nM IC50 Bioorg Med Chem Lett (2002) 12: 2931-2934 [PMID:12270177]
ChEMBL Inhibition of Inosine Monophosphate Dehydrogenase II (IMPDH II) B 7.82 pIC50 15 nM IC50 Bioorg Med Chem Lett (2002) 12: 3125-3128 [PMID:12372516]
ChEMBL Inhibitory activity tested against inosine-5'-monophosphate dehydrogenase 2 (IMPDH-II) enzyme B 7.82 pIC50 15 nM IC50 Bioorg Med Chem Lett (2003) 13: 3557-3560 [PMID:14505670]
ChEMBL Inhibitory concentration against Inosine-5'-monophosphate dehydrogenase 2 was determined B 7.82 pIC50 15 nM IC50 Bioorg Med Chem Lett (2002) 12: 3305-3308 [PMID:12392738]
ChEMBL Inhibition of human Inosine-5'-monophosphate dehydrogenase 2 B 7.82 pIC50 15 nM IC50 Bioorg Med Chem Lett (2002) 12: 2137-2140 [PMID:12127522]
ChEMBL Inhibition of human inosine monophosphate dehydrogenase IMPDH II B 7.85 pIC50 14 nM IC50 Bioorg Med Chem Lett (2003) 13: 543-546 [PMID:12565968]
ChEMBL Inhibitory activity against inosine monophosphate dehydrogenase IMPDH II B 7.85 pIC50 14 nM IC50 Bioorg Med Chem Lett (2003) 13: 547-551 [PMID:12565969]
ChEMBL Inhibition of human inosine-5'-monophosphate dehydrogenase 2 B 7.85 pIC50 14 nM IC50 J Med Chem (2002) 45: 2127-2130 [PMID:12014950]
ChEMBL Inhibition of human IMPDH2 expressed in Escherichia coli strain BL21(DE3) after 60 mins B 7.92 pIC50 12 nM IC50 Bioorg Med Chem (2010) 18: 8106-8111 [PMID:20934342]
ChEMBL Inhibition of human IMPDH2 B 7.96 pIC50 11 nM IC50 Bioorg Med Chem Lett (2006) 16: 3479-3483 [PMID:16621550]
Plasmodium berghei (target type: ORGANISM) [ChEMBL: CHEMBL612653]
ChEMBL HARVARD: Inhibition of liver stage Plasmodium berghei infection in HepG2 cells F 6 pIC50 1000 nM IC50 Proc Natl Acad Sci U S A (2012) 109: 8511-8516 [PMID:22586124]
Plasmodium falciparum (target type: ORGANISM) [ChEMBL: CHEMBL364]
ChEMBL HARVARD: Inhibition of blood stage Plasmodium falciparum Dd2 infection F 5.3 pIC50 >5000 nM IC50 Proc Natl Acad Sci U S A (2012) 109: 8511-8516 [PMID:22586124]

ChEMBL data shown on this page come from version 34:

Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]